← FDA Drug Approvals (Drugs@FDA)

ADAPALENE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WAYLIS THERAP · Approved 2016-01-05

Drug application

FDA Application #

ANDA204593

Application type

Abbreviated New Drug Application (Generic)

Brand name

ADAPALENE

Generic name

ADAPALENE

Active ingredients

ADAPALENE

Dosage form

SOLUTION

Route

TOPICAL

Marketing status

Prescription

Sponsor

WAYLIS THERAP

Manufacturer

CALL INC. (dba Rochester Pharmaceuticals)

First approval

2016-01-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown